FILE PHOTO: Scientific model of the molecule semaglutide which is the active ingredient in Novo Nordisk’s mega-blockbuster diabetes drug Ozempic and weight-loss drug Wegovy sits in the office of Mads Krogsgaard Thomsen in Hellerup, Denmark, October 3, 2023. REUTERS/Ali Withers/File Photo